ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,381.35
0.33%
Dow Jones
39,387.76
0.85%
Gold vs US Dollar
2,352.805
0.25%
Brent Oil
84.17
0.26%
Bitcoin
62,991.37
-0.09%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL)

  7. Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL) News

Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL)

Pharmaxis Limited - Sponsored Adr (Australia) (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PXSL
DateTimeSourceHeadlineSymbolCompany
22/07/200911:04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
13/07/200911:49Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
13/07/200900:22PR Newswire (US)Pharmaxis to Voluntarily De-List from NasdaqNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
30/06/200913:28Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
30/06/200913:28Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
30/06/200901:12PR Newswire (US)Pharmaxis Closes Share Purchase PlanNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
19/06/200913:56Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
16/06/200911:03Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
16/06/200902:11PR Newswire (US)Phase 3 Cystic Fibrosis Trial Results Presented at European ConferenceNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
04/06/200911:00Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
04/06/200901:19PR Newswire (US)Pharmaxis Announces Placement of $47 Million and Share Purchase PlanNASDAQ:PXSL
14/05/200911:04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
14/05/200900:33PR Newswire (US)U.S. FDA Accepts Aridol(TM) New Drug Application for ReviewNASDAQ:PXSL
04/05/200911:05Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
04/05/200909:02PR Newswire (US)Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis TrialNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
09/04/200911:03Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
07/04/200911:02Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
07/04/200900:02PR Newswire (US)New Pharmaxis Board AppointmentNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
06/04/200908:52PR Newswire (US)Pharmaxis Investor Conference CallNASDAQ:PXSL
01/04/200911:06Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
31/03/200923:58PR Newswire (US)Pharmaxis Announces Milestone in Phase III Trial for Cystic FibrosisNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
12/03/200910:04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
11/03/200906:10PR Newswire (US)Pharmaxis Appoints French Distributor for Aridol(TM)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
03/03/200914:14PR Newswire (US)Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test)NASDAQ:PXSL
02/03/200911:12Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
01/03/200922:41PR Newswire (US)Pharmaxis Announces New Drug Application Submission for Aridol(TM)NASDAQ:PXSL
18/02/200911:09Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
17/02/200913:22Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
17/02/200901:04PR Newswire (US)Pharmaxis Builds Senior Management TeamNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
06/02/200911:05Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
 Showing the most relevant articles for your search:NASDAQ:PXSL

Your Recent History

LSE
ITM
Itm Power
LSE
AGL
Angle
LSE
SAR
Sareum
LSE
TYM
Tertiary Minerals
LSE
PEN
Pennant
LSE
EMG
Man
LSE
GKP
Gulf Keystone Petroleum
NYSE
SPCE
Virgin Galactic
LSE
GDP
Goldplat
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved